Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$120K Sell
3,579
-399
-10% -$15K ﹤0.01% 840
2026
Q2
$159K Buy
3,978
+1,263
+47% +$46.7K ﹤0.01% 783
2026
Q1
$92K Sell
2,715
-1,158
-30% -$42.5K ﹤0.01% 870
2025
Q4
$142K Buy
3,873
+1,880
+94% +$66.9K ﹤0.01% 787
2025
Q3
$74K Sell
1,993
-1,080
-35% -$42.1K ﹤0.01% 877
2025
Q2
$125K Sell
3,073
-149
-5% -$6.17K ﹤0.01% 730
2025
Q1
$146K Buy
+3,222
New +$138K 0.01% 679
2022
Q3
– Sell
-481
Closed -$22K – 1089
2022
Q2
$22K Buy
+481
New +$24.3K ﹤0.01% 827
2021
Q4
– Sell
-563
Closed -$30K – 858
2021
Q3
$30K Sell
563
-3
-0.5% -$160 ﹤0.01% 671
2021
Q2
$28K Buy
566
+106
+23% +$4.99K ﹤0.01% 678
2021
Q1
$20K Buy
460
+146
+46% +$6.04K ﹤0.01% 670
2020
Q4
$12K Buy
314
+166
+112% +$6.06K ﹤0.01% 707
2020
Q3
$5K Buy
148
+75
+103% +$2.63K ﹤0.01% 755
2020
Q2
$3K Buy
73
+58
+387% +$2.17K ﹤0.01% 730
2020
Q1
$1K Sell
15
-67
-82% -$3.03K ﹤0.01% 759
2019
Q4
$4K Hold
82
– – ﹤0.01% 600
2019
Q3
$4K Buy
82
+6
+8% +$283 ﹤0.01% 639
2019
Q2
$3K Buy
76
+11
+17% +$495 ﹤0.01% 720
2019
Q1
$3K Buy
+65
New +$2.82K ﹤0.01% 652

Other funds holding UDR

CX Institutional's UDR Position: Q3 2026 in Review

CX Institutional reduced its UDR (UDR) stake by 10% in Q3 2026, selling an estimated $15K and leaving 3,579 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

CX Institutional first reported a position in UDR in Q1 2019 and has held it in 19 quarters since. The position peaked at $159K in Q2 2026. 17 funds tracked by Wall St. Rank hold UDR as of Q3 2026.

  • CX Institutional held 3,579 shares of UDR worth $120K as of Q3 2026.
  • CX Institutional sold 399 UDR shares in Q3 2026, an estimated $15K.
  • UDR made up ﹤0.01% of CX Institutional's portfolio in Q3 2026, its #840 holding.
  • CX Institutional first reported a position in UDR in Q1 2019 and has held it in 19 quarters since.
  • CX Institutional's UDR position peaked at $159K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held UDR as of Q3 2026.

Based on CX Institutional's 13F filing for Q3 2026, filed 2 Oct 2026.